This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
3-methylglutaconic Aciduria Type 2
Information about 3-methylglutaconic Aciduria Type 2: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of 3-methylglutaconic Aciduria Type 2
Most recent studies have shown that 3-methylglutaconic Aciduria Type 2 shares some biological mechanisms with 3-@methylglutaconic-aciduria-type-i, cardiomyopathies, cardiomyopathy-dilated, cyclic-neutropenia, dwarfism, dystrophy, genetic-diseases-x-linked, growth-disorders, growth-retardation, heart-diseases, heart-failure, hereditary-diseases, hypertrophy, mitochondrial-diseases, mitochondrial-myopathies, muscle-hypotonia, muscular-dystrophy, myopathy.
Among the many pathways, these few ones have gauged particular interests from scientists studying 3-methylglutaconic Aciduria Type 2, and have been seen in publications frequently: Aging, Apoptotic Process, Cardiac Conduction, Cell Death, Cell Wall Biogenesis, Cellular Process, Electron Transport, Electron Transport Chain, Excretion, Lipid Storage, Oxidative Phosphorylation, Pathogenesis, Phospholipid Scrambling, Programmed Cell Death, Protein Import, Reflex, Spermatogenesis, Translation, Transport, Tricarboxylic Acid Cycle
Quite a number of genes have been found to play important roles in 3-methylglutaconic Aciduria Type 2, such as BID, CYCS, DES, DMD, DMPK, DNASE1L1, DTNA, LDB3, LMNA, LPCAT1, LPCAT2, LPCAT3, MTSS1, PGS1, TAZ, WWTR1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.